Tilray (TLRY) Medical has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to patients in Australia. This launch marks Tilray Medical’s first medical cannabis edible offering in the country, providing patients with a sugar-free and vegan-friendly treatment option.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLRY:
- Tilray announces proposed reverse stock split, corresponding meeting
- Tilray price target lowered to 65c from $1 at Roth Capital
- 10 Barrel Brewing, Scout Campers unveil Camp Coldie beer
- Tilray’s Earnings Call: Mixed Sentiments and Strategic Focus
- Tilray price target lowered to $1 from $1.50 at Alliance Global Partners